Conference Call with CEO Jim Segermark – July 12th 3PM EST / 12PM PST
As a prospective investor we invite you to join InSitu Biologic’s CEO Jim Segermark for a conference call to answer your questions.
Jim will be available to address your questions regarding our Matrix BioHydrogel, and our pre-clinical stage, long-lasting and long-acting non-opiate painkiller, AnestaGel™ & AniGel™ as well as the Regulation A+ offering and making your online investment.
This format allows for you to interact as much or as little as you’d like and you can even just simply listen in.
Update: This webinar date has passed, however, the recording is available for you to view here: